D. Argentieri

发表

Comparison of the ulcerogenic properties of tepoxalin with those of non-steroidal anti-inflammatory drugs (NSAIDs)

D. W. Anderson, J. Wallace, G. Cirino, 1991, Agents and Actions.

1,3-Diarylcycloalkanopyrazoles and diphenyl hydrazides as selective inhibitors of cyclooxygenase-2.

D. Ritchie, Z. Sui, W. Murray, 2000, Bioorganic & medicinal chemistry letters.

1,3-Diarylcycloalkanopyrazoles and diphenyl hydrazides as selective inhibitors of cyclooxygenase-2.

D. Ritchie, Z. Sui, W. Murray, 2000, Bioorganic & medicinal chemistry letters.

Novel 6-oxo-6-naphthylhexanoic acid derivatives with anti-inflammatory and 5-lipoxygenase inhibitory activity

D. Ritchie, W. Murray, M. Wachter, 1991 .

Tissue-selective inhibition of prostaglandin synthesis in rat by tepoxalin: anti-inflammatory without gastropathy?

J. Wallace, D. McCafferty, W. McKnight, 1993, Gastroenterology.

N-(5-substituted) thiophene-2-alkylsulfonamides as potent inhibitors of 5-lipoxygenase.

T. Kirchner, D. Ritchie, M. Singer, 1997, Bioorganic & medicinal chemistry.

Pharmacokinetics and Pharmacodynamics of Tepoxalin after Single Oral Dose Administration to Healthy Volunteers

I. L. Smith, S. Waldman, T. Bjornsson, 1996, Journal of clinical pharmacology.

Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5-lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammation.

D. Ritchie, C. Lau, D. Argentieri, 1997, Prostaglandins, leukotrienes, and essential fatty acids.

Synthesis and 5-lipoxygenase inhibitory activities of some novel 2-substituted 5-benzofuran hydroxamic acids.

V. Nguyen, W. Hageman, M. Singer, 1994, Journal of medicinal chemistry.

N-hydroxyurea and hydroxamic acid inhibitors of cyclooxygenase and 5-lipoxygenase.

P. Connolly, S. K. Wetter, D. Ritchie, 1999, Bioorganic & medicinal chemistry letters.

Small-molecule immunostimulants. Synthesis and activity of 7,8-disubstituted guanosines and structurally related compounds.

D. Klaubert, A. Reitz, S. Bell, 1994, Journal of medicinal chemistry.

Guanosine Derivatives as Immunostimulants. Discovery of Loxoribine

Robert H. Chen, D. Klaubert, A. Reitz, 1994 .

Cytokine-modulating activity of tepoxalin, a new potential antirheumatic.

D. Ritchie, C. Lau, R. Plante, 1995, International journal of immunopharmacology.

[31] Adjuvant arthritis

J. Taurog, R. A. McReynolds, D. Argentieri, 1988 .

Increased Expression of Serine Palmitoyltransferase (SPT) in Balloon-injured Rat Carotid Artery

J. Carton, D. Uhlinger, D. Argentieri, 2001, Thrombosis and Haemostasis.

Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A.

D. Ritchie, L. Zhou, C. Lau, 1994, Journal of immunology.

In Vivo Activity of a Phospholipase C Inhibitor, 1-(6-((17β-3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), in Acute and Chronic Inflammatory Reactions

T. Kirchner, M. Singer, D. Cavender, 2004, Journal of Pharmacology and Experimental Therapeutics.

Robotic assay of sphingomyelinase activity for high throughput screening.

D. Ritchie, D. Argentieri, A. Barbone, 2000, Methods in enzymology.

Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries.

R. Falotico, J. Siekierka, T. Parry, 2005, European journal of pharmacology.

A primary immunodeficiency syndrome in Shar-Pei dogs.

F. Quimby, A. Rivas, E. S. Kimball, 1995, Clinical immunology and immunopathology.

Antinociceptive effects of a novel dual cyclooxygenase/5‐lipoxygenase inhibitor (tepoxalin) and its primary (carboxylic acid) metabolite (RWJ 20142) in acute tests in mice and rats

R. Raffa, M. Singer, J. Schupsky, 1995 .

Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.

D. Ritchie, S. Beers, M. Singer, 1997, The Journal of pharmacology and experimental therapeutics.

Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.

D. W. Anderson, D. Ritchie, M. Wachter, 1994, The Journal of pharmacology and experimental therapeutics.

Inhibitors of unactivated p38 MAP kinase.

Thomas M. Razler, M. Reuman, Xun Li, 2006, Bioorganic & medicinal chemistry letters.

Rapid detection of antigen-specific mouse IgE by enzyme-linked immunosorbent assay (ELISA).

R J Strouse, R. Strouse, D W Anderson, 1991, Journal of immunoassay.

Monitoring Inositol-Specific Phospholipase C Activity Using a Phospholipid FlashPlate®

M. Bembenek, T. R. Mullinax, C. Hou, 1999, Journal of biomolecular screening.

Design, synthesis, and biological activity of diiminoisoindolines as complement component 3a antagonists.

E. Grant, D. Guiadeen, D. Hlasta, 2001, Bioorganic & medicinal chemistry letters.

Synthesis and structure-activity relationships of 3,5-diarylisoxazoles and 3,5-diaryl-1,2,4-oxadiazoles, novel classes of small molecule interleukin-8 (IL-8) receptor antagonists.

D. Ritchie, D. Hlasta, M. Wachter, 2004, Bioorganic & medicinal chemistry letters.

Novel 6-Oxo-6-naphthylhexanoic Acid Derivatives with Anti-Inflammatory and 5-Lipoxygenase Inhibitory Activity.

D. Ritchie, W. Murray, M. Wachter, 1991 .